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Equilibrium constants (given M log &‘/M-l) hwc? kc41 dctrrmincd II~ #I 7.4 mod 4’C: t’or binding by par~inc intrinaic Rrctcrr (B,,.binding protein 
from the gut, rpceific far the ‘cebrhimin’ xcricd al’ Ca earrinaidr) or vitamin B,, or cyanecnb#lemin (IO.S), cyanacabinntrrids, n=ribrrnok rwt Z- 
ribazerlc.Fhoxp)letc (m&n t?tigmcntJ pradurcd by clwinp oTY the ‘cohulrmin’ aidc=ch:tin. a11 5; 3). tmd eyirnaeuhinrtnitlc in the prcrtncc af ;c: lCP* 
M ribwlc (5.6 rend indcpndcnt of rihazalc cnnccntnrtion), i.e. ribuxulcc~rtnlyrr~ the binding &l;hc eebinw~idr. tt ir prapaxcd that the xpscilirity 
of Intrinric Factor for the cabalnminr drpcndr on the prcrtcncc nl’thc ribrrznle Irrgmcnt in the cukhunin sidwh:~in ta promate IWI m%cntit\l change 
in canfwnwrian bckwc the cdrrinsid frqmcnt wn be bound. 
Intrinsic Fuctor; Vit;rmin Blr: Cu$rlkn; Ribaxolc 
1. INTRODUCTION 
Cocnzymes offer an unusually good opportunity for 
establishing the contribution of different parts of the 
molecule to the overall kinetics, energy and specificity 
of binding to macromolecules because of their ease of 
dissection into well-defined fragments, In spite of the 
current intense interest in molecular recognition, 
however, only two such examples appear to have been 
studied in detail. Comparison of the binding of the 
compiete NAD and of 6 fragments of varying length to 
the apo-form of L-lactate dehydrogenase r vealed a 
mechanism of molecular ecognition in which the bin- 
ding of AMP (and longer fragments) triggers a confor- 
mation change and nicotinamide mononucleotide can 
only bind in the presence (i.e. after the binding) of 
AMP [1,2]. Similar studies on the binding of NADPH 
and of several fragments to apo-dihydrofolate reduc- 
tase also suggested that reduced nicotinamide 
mononucleotide could bind only after a change in con- 
formation induced by some other fragment (not iden- 
tified, but larger than AMP) [3]. 
Vitamin B12 or cyanocobalamin (Fig. 1) is a member 
ed from BIZ at the point indicated to give cyanoa- 
quocobinamidc or Factor B, which exists as a mixture 
of 2 isomers involving interchange of the axial ligands 
[4], together with cu-ribazole (i.e. the base + ribose) and 
a-ribazolc-phosphate [5]. The single pcpride glycopro- 
tein Intrinsic Factor (IF), which binds BIZ in the gut 
(for attachment o, and transport through, the gut 
wall), is apparently unique amongst the mammalian 
BI2-binding proteins in its specificity for the cobalamin 
series [6]; it binds one Brz per pcptide [7] with a very 
high pH-independent (4.G 11) binding constant of 
10”-lO1o M-’ [8--l I], The nuclcotide side-chain clearly 
plays an important role in the mechanism of molecular 
recognition of the cobalamin by IF in humans and 
other mammals, but the basis of such action remains 
unknown; neither cyanocobinamide [,lO,l ] nor the 
base dimethylbenziminazole [7] appear to bind to IF. 
We report here a comparison of the binding by IF of 
B12 and of its components cyanocobinamide, cy- 
ribazole and cu-ribazole-phosphate, both separately and 
together, in order to identify the basis of the molecular 
recognition of cobalamins by IF. 
of the ‘cobalamin’ series of Co corrinoids, which all 
possess the nucleotide side-chain terminating in 
himethylbenziminazole as well as the amide side-chains 
shown in Fig. 1. The nucleotide side-chain can be clcav- 
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2. MATERIALS AND METHODS 
BIZ was obtained from Calbiochem, and *BQ (0.0447 pg and 
10.5 &i per ml) from Amersham International. Porcine IF (in vials 
containing 1000 units, where one unit binds 1 ng BIL) was obtained 
from Sigma; the total contents of each vial were dissolved in 1 ml 
phosphate-buffered solution pH 7.4 containing 0.1% bovine serum 
albumin (as recommended by Sigma) to give a stock solution which 
was stored at *-20°C. Cyanocobinamide [12], ribazole and ribazole- 
phosphate [5] were prepared as previously described. 
The very high value of the equilibrium constant for interaction bet- 
ween IF and B,z (ca 10’” M-l) necessitates the use of very low con- 
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Fig. I. Molccuiar slruclure of BIG, indicnling (---) the point of 
cleavage of ~hc side-chnln ta form cynnocobinamidc and ribilzo\c- 
phasphatr. 
ccnrralions and analysis by radiovcountinp (of l Bla), The assay 
[13,14] is bnscd on the fact 01~1, after equilibrium bc~wccn IF and 
*BIG, the i\ddi~iOn of clcs~ran.coaled Ch~lKOill will rapidly adsorb any 
unbound 811 and can be removed by cenlrifuention, and rhc concen- 
rrntion of IF-bound 91: in the supernalant dctcrminccl by counting. 
The binding conrrnn~s of other corrinoids (including ‘cold’ BIG) and 
fragmcnrs (such as ribazolc) can then be detcrmincd by competition 
with *Dir for IF. Each assay solution of 250 /rl contained 3.04 pmol 
IF, 0.07 pmol *Bl;r alld varying concentrations (IO”-lo-’ M) of the 
co~vpo~~ct~l~ to be tested and wcrc allawcd IO cquilibrnrc for 1 II. All 
experiments wcrc carried out in Rir at 4’C. In the following potential 
equilibria (with equilibrium constants numbered accordingly) it was 
assumed (cf. [7]) thai each protein molecule bound one 1312 or 
cyanocobinamidc and/or one ribarole (1: phosphate): 
IF + 13,~sIF* l3,2 
IF + cyatiocobinamidc~(ll’~cyanocobinamidc) 
II” + ribazolcS(IF* ribarolc) 
IF + cyanocobinamidc f ribazolee 
(IF~cyanocobinanride~ribarole) 
(I) 
(2) 
(3) 
(4) 
3. RESULTS 
Experilnents involving the direct equilibration of IF 
with *BIZ gave a value of Kl = 3.3 x 10’” M-’ or log 
K, = 10.5. Further studies using the competition assay 
with 1, 2, 5 and 10 x lo-” M added ‘cold’ J312 led to 
self-consistent values for ‘cold’ BIZ of KI = 3.3, 3.2, 3.9 
and 32; av. 3.4 x 10” M-l, also log KI = 10.5. Full 
details will be given elsewhere. 
lnlrirtl acudies on the binding of the component prrtd 
af B13 rhowed that neither ~y~~~~o~tn~rnid~, ibaxnte 
nor rikaxatc-phorphwtc atone nt canecnrrarians up CO 
10”’ M awed any nignifiennt displacement of *Bta 
fram IF, ix.. Ka and KS *e 10” lid”‘. Bisptaerfflenr was, 
hGWNZF, caused by 1: 1 mixrums of both 
cynnocabinemids + rtbanote and eyano~obi~arntd~ + 
ribnzole+hoxghate wir h SW% displacamcnr occurring 
at. 5,s and 4.6 K 10WJ M rrz+pcetivety, i.e. at 5 x 10” M 
(wirhin experimental error) in both cases. Very surprir;- 
in&, the amount of displacement did not vary with Ihe 
square of the conecnrrarion of the 1: I mixlure ns ex- 
yeetrd From equation (4), but linearly with conccntra- 
tion. This unexpected rer;ult was explored by varying 
the 2 components eeparntrly with the results shown in 
Table 1. The data show that for IO”“, la-” and 10” M 
cyanoeobinamide, the displacement of *BIZ is indcpen- 
dent of ribazolr concentration, at least down to 10’” rclz 
ribnzolcr studies at lower concfntrsrions were in- 
validated by the incrcnsing cr~ors involved, The *IO bin- 
ding dcpcndd only on rhe eoneeMration of 
cyanocobinamide and rhe 4 results at 10”’ and 10” 
cyanocabinamidc and ribaaole yield values of K2 = 5.3, 
3.0, 3.9 and 2.6; av. 3.7 x 10’ R/I”’ or log KJ = 5.6, 
4. DISCUSSION 
Our value of KI = 3.3 x 10’” M” (log KI = 103) for 
binding of E3,2 to porcine IF at 4°C compares well with 
the value expected by extrapolation of the values 
reported for human IF over the range from 38OC down 
to 22”C, viz. 0.14 to 1.3 x 10” Mm’ [9], 
Table I 
Binding of cyanocobinamide and ribazolc to Intrinsic Farlor in come 
pcGrian with radio-labelled *Blz 
Cont./M % *I311 bound to IF in the presence of a fixed 
concentration of one component (given below) and 
varying concentralions (PCC left) of the second 
component (cyanocobinamide c ribaeolc) 
Cyanocobinaniide Ribazole 
10-q M lo-” M 
Ribazolc 
10-J M 
10-0 27 
10-n 29 
lO-7 31 
10-h 32 
10-S 42 
10-j 39 
IO-” 
100 100 
94 IO0 
99 99 
94 100 
88 84 
42” 39R 
28” 2B0 
10-2 2 
a Used for calculating equilibrium canstants (see text) 
The assay (see section 2) involved competition between *B~z and 
(cyanocobinamide -t ribazole) for IF. The results (average of 3 ex- 
periments at each concentration) are given in the form of *i&z bound 
to IF in the presence of cyanocobinamide + ribazole as a percentage 
of the *I312 bound in their absence. (Actual concentrations of 
cyanocobinamide and of ribazole were 1.2 and 1.4 x lo-” M respec- 
tively; here all taken as I.0 x IO-” M for simplicity.) 
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8ur resufts confirm that cyanocobinamide alone 
does not displucc%14 Prom IF(cf. [l&ill) nnd in atddi- 
rlon show (a) that ribaxole und ribanole-phosphate 
alone will not do so, i.e, IF will not binll alor~e to either 
of the 2 complete fragments (cyanocobinamidc, 
ribazole-phosphate) which together (with alimination 
of I-f@) form EJIP; (b) that cyanocabinamide and 
ribarelc (or tiba%ote=plrsephate) tergether will do so, i.c. 
there ix some form of cooperative inrcrartion; and Cc) 
that ribnzole and ribazole-phosphate! have virtually the 
same effect, i.e. the phosphate does nor play my 
significant additional role. If one assumes that this 
cooperative binding ot’ the 2 fragments with IF involves 
the same sites as with B,a itself, then the inability of 
either fragment alone to displace *I312 em bc used to 
derive values of log E\“:! and log KS < 3 For binding 
cyenocobinamide and ribazolc separately at the relc+ 
vant sites. We have further shown that, in the presence 
of same minimum concentration (10’” M) of ribazole, 
the observed binding depends only on the concentra- 
tion of added cyanacabinamide according co equation 
(2) with log Ka = 5.6. 
We suggest hat, in rhc binding of eyanocobinamide 
with ribazole to IF, the first step involves the binding 
of ribazole which causes a change from an inactive con- 
formation PI to the active Pz; this is able to bind 
cyanocobinamide, giving Pt and followed by the 
dissociation of ribazole (at least at the concentrations 
used). In other words, rihazole catalyses a conforma- 
tion change. Certain enzymes are reported to require an 
analogous ligand-induced preconditioning or matura- 
tion before the substrate can be bound [15,16], though 
no example appears to have been reported hitherto 
among metalloenzymes [17]; an instructive example is 
phosphofructokinasc, where ATP reversibly catalyses 
the inter-conversion of inactive and active conforma- 
tions [15]. By analogy we suggest hat, in the binding 
of BIZ to IF, the first step involves binding the 
nucleotide side-chain (containing ribazolc) which 
causes the change in conformation and allows the cor- 
rinoid part to be bound, accompanied by a further 
change in conformation; the ribazole, being part of the 
covalently attached side-chain, remains bound to IF. It 
is, in fact, likely that most of the enhanced binding con- 
stant of B12 (log K, = 10.5) compared to that of 
cyanocobinamide in the presence of ribazole (log K2 = 
5.6) would be contributed by the additional binding of 
ribazole (log KS I 3 when free) which could be 
significantly enhanced when incorporated into the 
nucleotide side-chain of B12. This two-step binding 
could explain the report that the binding of B12 to IF 
shows saturation kinetics [lo], as well as inducing a 
significant conformation change in IF [l8], 
There is an obvious parallel between the binding of 
NAD by lactate dehydrogenase (see section 1) and of 
BU by IF. Both coenzymes consist of a functional frag- 
ment (nicotinamide, corrinoid) and a recognition frag- 
mcnt (AMP, ribnaals), end the funetiarnal t’ra$mcrrr ran 
bind only ra o confermnrian indutecl by the prior bin= 
ding of the recognition fragment. The differclncc bct- 
wcen the clrtollytic function Of ribaxole and the 
xtoichiometric binding of AMP may bc more apparent 
than real; Blnrling al” ribaxelc la likely to be obre~*vcd nt 
higher concentrations (and the limit af &+a < IO’ allows 
for a binding CWIXIPII~ camparnblc to that OS AMP), 
and no testf have been made for catalysis by IOW@F 
levels of AMP, 
Qur results show that IF exhibits a rpecificify of log 
K 2 7.5 for the cobnlnmin Bl;a over the cabinamide (cf. 
lag A’ = IQ.5 and ~3 respectively) and that this 
specificity can be ascribed to the role of the nucleotide 
side-chain in promoting or eatnlysing a key conforma- 
tion change required before fhe main functional (i.e. 
corrinoid) part of the molecule can bc bound. 
Analogous mechanisms have IIOW been found in all 3 
examples of coenzymc binding so far studied (involving 
NAB [l], NRDPI-I [3] and now E312) and may therefore 
rqXc%XIt n fairly common device used in the p~occlfs Of 
molecular recognition of coenzymes in general, 
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